Skip to main content
JAMA Network logoLink to JAMA Network
. 2021 Oct 6;326(18):1874. doi: 10.1001/jama.2021.18721

Incorrect Patient Data Reported

PMCID: PMC8495605  PMID: 34613358

In the Editorial titled “Vasopressin and Steroids as Adjunctive Treatment for In-Hospital Cardiac Arrest,”1 published online in the September 29, 2021, issue of JAMA, there was a factual error regarding the proportion of patients who received targeted temperature management in the VAM-IHCA trial. The sentence that read, “In the VAM-IHCA trial, all patients received targeted temperature management, although several differences existed between study groups during the postresuscitation period” should have read, “In the VAM-IHCA trial, the proportion of patients who received targeted temperature management was comparable in the intervention group (27%) and in the placebo group (26%), although several differences existed between study groups during the postresuscitation period.” This article was corrected online.

Reference

  • 1.Haukoos J, Douglas IS, Sasson C. Vasopressin and steroids as adjunctive treatment for in-hospital cardiac arrest. JAMA. Published online September 29, 2021. doi: 10.1001/jama.2021.15460 [DOI] [PubMed] [Google Scholar]

Articles from JAMA are provided here courtesy of American Medical Association

RESOURCES